Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P0
Near historical low
vs 3Y Ago
-9168560.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -120698560.61% |
| Q3 2025 | -4.00% |
| Q2 2025 | 28.24% |
| Q1 2025 | -51.21% |
| Q4 2024 | 35.42% |
| Q3 2024 | 12.97% |
| Q2 2024 | -1.27% |
| Q1 2024 | -47.85% |
| Q4 2023 | -2.28% |
| Q3 2023 | 3.59% |
| Q2 2023 | -62.87% |
| Q1 2023 | 8.84% |
| Q4 2022 | 13.16% |
| Q3 2022 | 51.42% |
| Q2 2022 | -47.19% |
| Q1 2022 | -30.43% |
| Q4 2021 | -22.25% |
| Q3 2021 | 55.48% |
| Q2 2021 | -71.91% |
| Q1 2021 | 11.85% |
| Q4 2020 | -10.32% |
| Q3 2020 | -102.80% |
| Q2 2020 | 15.92% |
| Q1 2020 | -6.13% |
| Q4 2019 | -12.80% |
| Q3 2019 | 42.65% |
| Q2 2019 | -64.96% |
| Q1 2019 | 36.21% |
| Q4 2018 | -16.79% |
| Q3 2018 | 1.65% |
| Q2 2018 | -14.74% |
| Q1 2018 | 14.21% |
| Q4 2017 | -10958.66% |
| Q3 2017 | 101.42% |
| Q2 2017 | -37.04% |
| Q1 2017 | 29.64% |
| Q4 2016 | 43.67% |
| Q3 2016 | 35.35% |
| Q2 2016 | -127.28% |
| Q1 2016 | 41.24% |